Inovelon (rufinamide)

Submitted by Mark@Epilepsy Action on 21 November, 2007 - 10:00.

Eisai has recently released, in the UK, a new anti-epileptic drug Inovelon (its generic name is rufinamide). It is used for seizures associated with Lennox-Gastaut syndrome in patients aged four years and older. Inovelon is licensed to be added to existing anti-epileptic drugs but is not licensed as a single drug treatment.

Printer-friendly version

Epilepsy Helpline

UK freephone 0808 800 5050
International +44 113 210 8850
Email: helpline@epilepsy.org.uk
Txt msg: 07797 805 390 info

Epilepsy Action blog

Media Blog for October 2008

During October, Epilepsy Action took part in 22 radio interviews, and 36 online features.

Channel 4 documentary about Young Carers (9-14 yrs)

Epilepsy Action has been approached by a documentary production company who are developing a film for Channel 4 focussing on young carers in the UK. The company are looking to work with children aged 9-14 years who are just about the only carer for another family member with epilepsy.

Media blog for September 2008

Welcome to our new Epilepsy Action monthly media blog. It would be impossible to report on all our media coverage (you’ll see why if you visit our press releases page). I want to give you a snapshot of just some of the work we have been involved with to help raise awareness of epilepsy in the media - in the press, on the radio, online and on the television.